14:00 - 15:15
ET
Webcast
Advancing immunotherapy for blood cancers - Innovation in Research
Join Dr. Natasha Kekre, hematologist at The Ottawa Hospital and researcher, as she explores the latest advances in immunotherapy for blood cancers, including:
- The evolution and impact of CAR-T cell therapy and bispecific antibodies
- Emerging trends and future directions in immunotherapy for leukemia, lymphoma, multiple myeloma, and other blood cancers
Dr. Kekre leads BioCanRx’s Canadian-led Immunotherapies in Cancer (CLIC-01) research trial, of which LLSC is a funding partner.
This webcast may be more complex than our usual webcasts, making it ideal for audiences with an interest in advanced research and technologies applied to medical science.
Dr. Natasha Kekre
Dr. Natasha Kekre is a hematologist in the transplant and cellular therapy program at The Ottawa Hospital, and a scientist at the Ottawa Hospital Research Institute.
This event is in partnership with:
